Business
Cardax Attracts $2.75M in Investment
Cardax Attracts $2.75M in Investment.
About this update from Cardax Inc
[{"type":"text","content":"\n\n\n\nCardax Attracts $2.75M in Investment\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnsbls{\nBORDER-LEFT:black 1pt solid\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prnsbbs{\nBORDER-BOTTOM:black 1pt solid\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnrbrs{\nBORDER-RIGHT:black 1pt solid\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnsbts{\nBORDER-TOP:black 1pt solid\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n\n\n\n\n\n\nCardax Attracts $2.75M in Investment\nFunds to Support ZanthoSyn® Marketing Campaign for GNC National Expansion\nPR Newswire\nHONOLULU, Aug. 28, 2017\n\n\n\nHONOLULU, Aug. 28, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) reported today that it has received investment subscriptions of approximately $2.75 million since the filing of the Company's Form 10-Q on August 11, 2017. Approximately $1.2 million of the subscriptions have been funded to-date, and the remaining subscriptions of $1.55 million are expected to be funded by September 30, 2017. These investments are under the Company's previously disclosed Unit Offering, which is no longer accepting subscriptions.\n\n\n \n \n\n \nThe funds will support the launch of Cardax's national ZanthoSyn marketing campaign in connection with the recently announced General Nutrition Corporation (\"GNC\") national expansion. The marketing campaign will focus on physician awareness and GNC store personnel education, in addition to general corporate purposes.\n\n\"We have been very pleased with the enthusiastic physician endorsement of ZanthoSyn, accelerating sales at Hawaii GNC stores, the NIH anti-aging testing announcement, and the recent purchase order from GNC to stock ZanthoSyn in all of its more than 3,200 GNC corporate stores nationwide,\" said David G. Watumull, Cardax CEO. \"This financing now enables us to initiate the national expansion of the physician and GNC store focused marketing strategy that has worked so well in Hawaii.\" \n\nAbout Cardax\n\nCardax devotes substantially all of its efforts to developing and commercializing safe...